Foot-and-mouth disease control using vaccination: South African experience

Developments in Biologicals

Volumn 119, Issue , 2005, Pages 51-62

  Bruckner G K ^a   Vosloo, W ^b   Cloete, M ^b   Dungu, B ^c   Du Plessis, B J A ^d  

^a Directorate of Veterinary Services   (South Africa)

^b ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^c Onderstepoort Biological Products   (South Africa)

^d Directorate of Veterinary Services   (South Africa)

Author keywords

Adjuvant; African buffalo; Control strategies; Foot and mouth disease; Non structural proteins; Pigs; Small stock; South Africa; Vaccinations

Indexed keywords

VIRUS ANTIBODY;

ANIMAL; ANIMAL DISEASE; BLOOD; BUFFALO; CATTLE; DOMESTIC ANIMAL; EPIDEMIC; FOOT AND MOUTH DISEASE; GOAT; INFECTION CONTROL; REVIEW; SHEEP; SOUTH AFRICA; VACCINATION; WILD ANIMAL;

ANIMALS; ANIMALS, DOMESTIC; ANIMALS, WILD; ANTIBODIES, VIRAL; BUFFALOES; CATTLE; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; FOOT-AND-MOUTH DISEASE; GOATS; SHEEP; SOUTH AFRICA; VACCINATION;

EID: 20344386498     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (30)

1. Brückner GK, Vosloo W, Kloeck PELG, Weaver DB: Eradication of foot-and-mouth disease by using stamping-out and vaccination: the examples of the outbreaks due to serotype O and SAT-1 in South Africa, in Dodet B, Vicari M (eds): Foot-and-mouth Disease: Control Strategies. Paris, Amsterdam, New York, Oxford, Shannon, Tokyo, Elsevier, 2003, pp 135-143.
2. Brückner GK, Vosloo W, Du Plessis BJA, Kloeck PELG, Connoway L, Ekron MD, Weaver DB, Dickason CJ, Schreuder FJ, Marais T, Mogajane ME: Foot and mouth disease: the experience in South Africa. Rev. Sci. Tech. OIE. 2002;21(3):751-764.
3. Thomson GR: Foot and mouth disease, in Coetzer JAW, Thomson GR, Tustin RC (eds): Infectious diseases of livestock with special reference to southern Africa. Cape Town, London, New York, Oxford University Press, 1994, pp 825-952.
4. Thomson G., Vosloo W, Bastos ADS: Foot and mouth disease in wildlife. Virus Res 2003;91:145-161.
5. Vosloo W, Bastos ADS, Michel A, Thomson GR: Tracing movement of African buffalo in southern Africa. Rev Sci Tech OIE 2001;20:630-639.
6. Thomson GR, Vosloo W, Bastos ADS: The epidemiology and control of foot-and-mouth disease in sub-Saharan Africa, in Dodet B, Vicari M (eds): Foot-and-mouth Disease: Control Strategies. Paris, Amsterdam, New York, Oxford, Shannon, Tokyo, Elsevier, 2003, pp 125-134.
7. Vosloo W, Bastos ADS, Sangare O, Hargreaves SK, Thomson GR: Review of the status and control of foot-and-mouth disease in sub-Saharan Africa. Rev Sci Tech Off Int Epiz 2002;21(3):437-449.
8. th Ed. OIE, Paris, 2003, pp 85-97.
9. Pluimers FH: The use of emergency vaccination and its implication for trade, in Dodet B, Vicari M (eds): Foot-and-mouth Disease: Control Strategies. Paris, Amsterdam, New York, Oxford, Shannon, Tokyo, Elsevier, 2003, pp 203-206.
10. Vosloo W, Boshoff K, Dwarka R, Bastos A: The possible role that buffalo played in the recent outbreaks of foot-and-mouth disease in South Africa. Ann N Y Acad Sci 2002b;969:187-190.
11. Bastos ADS: Molecular epidemiology and diagnosis of SAT-type foot-and-mouth disease in southern Africa. PhD thesis. University of Pretoria, 2001, pp 1-148.
12. Bastos AD, Anderson EC, Bengis RG, Keet DF, Winterbach HK, Thomson GR.: Molecular epidemiology of SAT3-type foot-and-mouth disease. Virus Genes 2003;27:283-290.
13. Vosloo W, Bastos AD, Kirkbride E, Esterhuysen JJ, Janse van Rensburg D, Bengis RG, Keet DF, Thomson GR: Persistent infection of African buffalo (Syncerus caffer) with SAT-type foot-and-mouth disease viruses: rate of fixation of mutations, antigenic change and interspecies transmission. J Gen Virol 1996;77:1457-1467.
14. Bastos ADS, Haydon DT, Forsberg R, Knowles NJ, Anderson EC, Bengis RG, Nel LH, Thomson GR: Genetic heterogeneity of SAT-1 type foot-and-mouth disease viruses in southern Africa. Arch Virol 2001;146:1537-1551.
15. Bastos ADS, Haydon DT, Sangare O, Boshoff CI, Edrich JL, Thomson GR: The implications of viral diversity within the SAT-2 serotype for control of foot-and-mouth disease in sub-Saharan Africa. J Gen Virol 2003;84:1595-1606.
16. Vosloo W, Kirkbride E, Bengis RG, Keet DF, Thomson GR: Genome variation in the SAT types of foot-and-mouth disease viruses prevalent in buffalo (Syncerus caffer) in the Kruger National Park and other regions of southern Africa, 1986-1993. Epidem Infect 1995;114:203-218.
17. Hunter P: The performance of South African Territories serotypes of foot-and-mouth disease antigen in oil-adjuvanted vaccines. Rev Sci Tech Off Int Epiz 1996;15(3):913-922.
18. Hunter P: Vaccination as a means of control of foot-and-mouth disease in sub-saharan Africa. Vaccine 1998;16(2/3):261-264.
19. Bastos ADS, Boshoff CI, Keet DF, Bengis RG, Thomson GR: Natural transmission of foot-and-mouth disease virus between African buffalo (Syncerus caffer) and impala (Aepyceros melampus) in the Kruger National Park, South Africa. Epid. Infect 2000;124:591-598.
20. Van Bekkum JG, Bool PH, Vermeulen CJ: Experience with the vaccination of pigs for the control of foot-and-mouth disease in the Netherlands. Tijdschr Diergeneeskd 1967;92(1):87-97.
21. Bahnemann HG, Mesquita JA: Oil-adjuvanted vaccine against foot-and-mouth disease. Bull Centro Panamericano Fiebre Altosa 1987;53:25-30.
22. Dora JFP, Coelho Nunes JC, Goular de Silveira JC, Jorgens EN, Rosenberg FJ, Astudillo VM: Epidemic of foot-and-mouth disease, in Bage RS (ed): Brazil, 1980. Evaluation of two systems of vaccination. Bull Centro Panamericano Fiebre Altosa, 1984;49-50:11-17.
23. Barnett PV, Pullen L ,Williams L, Doel TR: International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine 1996;14(13):1187-1198.
24. Iyer AV, Ghosh S, Singh SV, Deshmukh RA: Evaluation of three 'ready to formulate' oil adjuvants for foot-and-mouth disease vaccine production. Vaccine 2001;19:1097-1105.
25. Cox SJ, Barnett PV, Dani P, Salt JS: Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine 1999;17:1858-1868.
26. Barnett IV, Cox SJ, Aggarwal N, Gerber H, McCullough KC: Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine. Vaccine 2002;20:3197-3208.
27. Patil PK, Bayry J, Ramakrishna C, Hugar B, Misra LD, Natarajan C: Immune responses of goats against foot-and-mouth disease quadrivalent vaccine: comparison of double-oil emulsion and aluminium hydroxide gel vaccines in eliciting immunity. Vaccine 2002;20:2781-2789.
28. Hunter P, Bastos ADS, Esterhuysen JJ, van Vuuren C de WJ: Appropriate foot-and-mouth disease vaccines for southern Africa. All Africa Conference on Animal Agriculture, Pretoria, South Africa 1996;2.2.7:1-4.
29. Golding SM, Hedger RS, Talbot P: Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease. Res Vet Sci 1976;20(2):142-147.
30. Kitching RP, Banett PV, Donaldson AI: Foot and Mouth Disease, in Manual of Standards for Diagnostic Tests and Vaccines. OIE, 2000, pp 77-92.